SANOFICONRBSESANOFI CONS HEALTHC IND LHighNeutral
Announced Wed, 28 Oct, 2026 · 18:21 IST

Q3 revenue rises 12%; nine-month profit after tax rises 23%

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

The Board approved unaudited results for the quarter and nine months ended September 30, 2026. Q3 revenue was Rs 2,631 million, up 12%, while profit after tax rose 22% to Rs 766 million. Nine-month revenue rose 16% to Rs 7,280 million and profit after tax rose about 23% to Rs 2,132 million. Earnings per share rose 22% to Rs 33.26. The limited review found no material issues. Prior recalls and relaunches limit year-on-year comparisons.

Likely market impact

Revenue and profit growth is positive for shareholders and may lift the share price, though recall and relaunch effects limit comparisons.